novan

Durham pharma Novan to sell assets in bankruptcy case

Posted by WRAL TechWire | Sep 11, 2023

Durham drugmaker Novan has agreements in place to sell its assets as the company’s bankruptcy moves forward.

Durham biotech Novan to sell assets, files for bankruptcy

Posted by WRAL TechWire | Jul 17, 2023

Durham biotech Novan has filed for bankruptcy and struck a deal to sell most of its assets for $15 million. Here’s what’s happening.

Durham pharma Novan slashes 50% of workforce, mulls sale of assets

Posted by WRAL TechWire | Jun 1, 2023

Drug development firm Novan is cutting 50% of its workforce – 39 employees – and is looking to sell or license some of its product lines.

Durham-based pharmaceutical firm Novan reports bigger losses than expected

Posted by WRAL TechWire | May 15, 2023

The drug development company posted revenue and a loss that fell short of Street forecasts on Monday.

Durham dermatology firm submits gel targeting ‘viral skin infection’ to FDA

Posted by WRAL TechWire | Jan 9, 2023

Novan, a medical dermatology firm, has submitted a new drug application to the FDA and hopes to win approval for it in early 2024.

Triangle drug firm Novan subsidiary lands $5M upfront in licensing deal

Posted by WRAL TechWire | Dec 21, 2022

EPI Health, a subsidiary of Durham-based pharmaceutical firm Novan, has landed a licensing deal with Japan-based Sato Pharmaceuticals for a facial treatment.

Earnings reports: Bioventus, Humacyte, Guerrilla RF, Novan, Liquidia & more

Posted by WRAL TechWire | Aug 12, 2022

It’s been a busy week for North Carolina public companies in tech and life science reporting financial results. Here’s a roundup.

Durham-based dermatology firm Novan buys SC company in deal worth up to $50M

Posted by WRAL TechWire | Mar 11, 2022

Dermatology firm Novan, which hopes to be nearing FDA approval for its lead product compound, is gearing up for a potential launch by acquiring South Carolina-based EPI Health.